Archives

by in
Entry Author Date Location
Tesaro, Vertex, Infraredx, & More Boston Life Sciences Headlines 06/29/12 Boston
After Big Oops, Vertex Plows Ahead With Cystic Fibrosis Drug Combo 06/28/12 Boston
Three Good Things About BIO 2012, and Four Not-so-Good 06/18/12 National
Vertex, N-of-One, Flexion & More Boston Life Sciences News 06/01/12 Boston
Vertex Shares Drop on Mistake in Cystic Fibrosis Drug Data 05/29/12 Boston
Boston Life Sciences News From Vertex, Eleven, RXi, & More 05/11/12 Boston
Vertex Shares Boom on Cystic Fibrosis Results 05/07/12 Boston
Some Tongue-in-Cheek Fantasy Baseball (and Biotech) Picks 03/26/12 National
Kala Funnels $6.2M Into New Drugs for Eye and Lung Diseases 03/19/12 Boston
In Boston Life Sciences News: Akili, Kala, And Genocea 03/16/12 Boston
San Diego Life Sciences Roundup: Amylin, Optimer, and the Economy 02/03/12 San Diego
Vertex’s Big Day Felt Like Moon Landing, Seattle Researcher Says 02/01/12 Boston
Vertex Gets FDA Go-Ahead To Sell New Cystic Fibrosis Drug 01/31/12 Boston
Vertex Names Jeff Leiden as New CEO, Staring Down Tough Competition 12/15/11 Boston
Vertex Seeks FDA Green Light for Cystic Fibrosis Drug, Second Potential Hit of Big Year 10/19/11 Boston
(Mis)Understanding Drug Discovery: It’s Much Harder Than Rocket Science 09/07/11 Seattle
Pulmatrix Wins $14M to Back Drug For Cystic Fibrosis And Other Lung Ailments 08/15/11 Boston
Vertex CF Drug Delivers, Follica Patent Application Reveals Tech, RXi Buys Apthera, & More Boston-Area Life Sciences News 04/01/11 Boston
Ligand CEO Outlines Strategy, Arena Rebalances its Debt, Venture Biotech Versus Pharma Debate Flares Anew, & More San Diego Life Sciences News 03/31/11 San Diego
Editor’s Picks: Xconomy Boston’s Top 20 Stories of the First Quarter 03/31/11 Boston
Vertex CF Drug Shines in Late-Stage Study in Children 03/29/11 Boston
Think Obamacare Will Suffocate New Drug Development With Price Controls? Think Again 03/21/11 National
Where Are Tomorrow’s Blockbuster Biotech Drugs Coming From? You Might be Surprised 03/14/11 National
Targeted Genetics, Re-invented as AmpliPhi, Bets on Anti-Bacterials, Moves HQ to London 03/09/11 Seattle
Quanterix Partners With Novartis, Athenahealth and Microsoft Sync Up, Vertex Nails Clinical Trial, & More Boston-Area Life Sciences News 02/25/11 Boston
Vertex Stock Up 15 Percent on CF Data 02/23/11 Boston
Vertex Nails Pivotal Study for Cystic Fibrosis, Racing Toward Market With Second Drug 02/23/11 Boston
Philanthropist John Flatley Starts Venture Group to Back New Cystic Fibrosis Treatments 01/27/11 Boston
Vertex Drug Gets Speedy FDA Review, BSX Buys Atritech, Ironwood Strikes Another Deal, & More Boston-Area Life Sciences News 01/21/11 Boston
Patients’ Parents Upset By FDA Panel’s Rejection of Lilly/Alnara’s Cystic Fibrosis Drug 01/19/11 Boston
Page 2 of 4 « previous page · next page »